In collaboration with the Soham Foundation, the initiative focused on perimenopause, menopause, and hormone replacement therapy awareness at BESCOM’s Bengaluru headquarters.
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Approval for 5 mg and 10 mg strengths, bioequivalent to Farxiga®, strengthens Lupin’s anti-diabetic portfolio in US market
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
